| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | SLC25A39 |
| Uniprot No | Q9BZJ4 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 1-359aa |
| 氨基酸序列 | MADQDPAGISPLQQMVASGTGAVVTSLFMTPLDVVKVRLQSQRPSMASELMPSSRLWSLSYTKLPSSLQSTGKCLLYCNGVLEPLYLCPNGARCATWFQDPTRFTGTMDAFVKIVRHEGTRTLWSGLPATLVMTVPATAIYFTAYDQLKAFLCGRALTSDLYAPMVAGALARLGTVTVISPLELMRTKLQAQHVSYRELGACVRTAVAQGGWRSLWLGWGPTALRDVPFSALYWFNYELVKSWLNGFRPKDQTSVGMSFVAGGISGTVAAVLTLPFDVVKTQRQVALGAMEAVRVNPLHVDSTWLLLRRIRAESGTKGLFAGFLPRIIKAAPSCAIMISTYEFGKSFFQRLNQDRLLGG |
| 预测分子量 | 39,2 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
1. **"SLC25A39 is necessary for mitochondrial glutathione import in mammalian cells"**
- **作者**: Chen et al., 2021
- **摘要**: 研究通过重组人源SLC25A39蛋白的功能分析，揭示其在线粒体谷胱甘肽转运中的关键作用，并验证其缺失导致氧化应激敏感性增加。
2. **"Structural basis of SLC25A39 activity in iron homeostasis"**
- **作者**: Zhang et al., 2022
- **摘要**: 利用重组SLC25A39蛋白的冷冻电镜结构解析，阐明其底物结合域特征及在铁代谢中的分子机制。
3. **"SLC25A39 deletion disrupts cellular heme biosynthesis via mitochondrial transport"**
- **作者**: Wang et al., 2023
- **摘要**: 通过重组蛋白体外实验，证明SLC25A39参与血红素前体运输，其缺失导致线粒体代谢通路异常。
4. **"Mitochondrial SLC25A39 modulates cellular iron trafficking and stress response"**
- **作者**: Hughes et al., 2021
- **摘要**: 研究重组SLC25A39蛋白的体外功能，发现其通过调控铁硫簇合成影响细胞铁稳态及氧化应激应答。
(注：以上文献为示例，实际引用需以真实发表论文为准。)
SLC25A39 is a member of the solute carrier family 25 (SLC25), a group of mitochondrial carrier proteins responsible for transporting metabolites, nucleotides, amino acids, and lipids across the mitochondrial inner membrane. These transporters play critical roles in maintaining cellular energy production, redox balance, and metabolic homeostasis. SLC25A39. specifically, has garnered attention for its potential involvement in mitochondrial glutathione (GSH) metabolism. GSH is a key antioxidant that protects cells from oxidative damage, and its mitochondrial pool is essential for maintaining proper redox signaling and preventing oxidative stress-induced cell death. Although the exact substrate specificity of SLC25A39 remains under investigation, studies suggest it may facilitate GSH transport into mitochondria or regulate GSH homeostasis through indirect mechanisms.
Recombinant SLC25A39 protein is engineered for in vitro studies to elucidate its biochemical properties, structural features, and interaction partners. It is typically produced using heterologous expression systems, such as *E. coli* or mammalian cell cultures, followed by purification via affinity tags (e.g., His-tag). This recombinant tool enables researchers to analyze transport kinetics, substrate binding, and the impact of mutations on protein function. Structural studies, including cryo-EM or X-ray crystallography, aim to resolve its 3D conformation, providing insights into its transport mechanism.
Dysregulation of SLC25A39 has been linked to pathologies such as anemia, neurodegenerative disorders, and cancer, highlighting its physiological relevance. For example, in mammals, SLC25A39 deficiency disrupts mitochondrial iron-sulfur cluster biogenesis, impairing erythroid development. Recombinant SLC25A39 also serves as a reagent for drug screening, targeting mitochondrial dysfunction in diseases. Ongoing research focuses on its role in metabolic adaptation, aging, and response to oxidative stress, positioning it as a potential therapeutic target for conditions involving mitochondrial redox imbalance.
×
